{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:15:11Z","timestamp":1788480911478,"version":"build-2803163510"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T00:00:00Z","timestamp":1756944000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG073321"],"award-info":[{"award-number":["R01AG073321"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K24AG080025"],"award-info":[{"award-number":["K24AG080025"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["K02AG076883"],"award-info":[{"award-number":["K02AG076883"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","award":["AARG231077773"],"award-info":[{"award-number":["AARG231077773"]}],"id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s11606-025-09832-9","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T12:51:02Z","timestamp":1756990262000},"page":"134-142","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["COVID-19 Pandemic-induced Healthcare Disruption and Chronic Kidney Disease Progression"],"prefix":"10.1007","volume":"41","author":[{"given":"Richard","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Abraham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Conderino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania","family":"Kanchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saul B.","family":"Blecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A.","family":"Dodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna E.","family":"Thorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Charytan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara A.","family":"McAdams-DeMarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7642-9773","authenticated-orcid":false,"given":"Wenbo","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,4]]},"reference":[{"issue":"6","key":"9832_CR1","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1007\/s11255-023-03480-w","volume":"55","author":"JJ Jiang","year":"2023","unstructured":"Jiang JJ, Jenkins ZM, Crocker KM, Castle DJ. Impact of the COVID-19 pandemic on access to healthcare, physical and mental health among patients with chronic kidney disease in Victoria, Australia. Int Urol Nephrol. Jun 2023;55(6):1635-1640. https:\/\/doi.org\/10.1007\/s11255-023-03480-w","journal-title":"Australia. Int Urol Nephrol."},{"issue":"4","key":"9832_CR2","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1053\/j.ajkd.2023.04.001","volume":"82","author":"P Natale","year":"2023","unstructured":"Natale P, Zhang J, Scholes-Robertson N, et al. The Impact of the COVID-19 Pandemic on Patients With CKD: Systematic Review of Qualitative Studies. Am J Kidney Dis. Oct 2023;82(4):395-409 e1. https:\/\/doi.org\/10.1053\/j.ajkd.2023.04.001","journal-title":"Am J Kidney Dis."},{"key":"9832_CR3","doi-asserted-by":"crossref","unstructured":"Zhao R, Zhou Q, Xu H, Shen Q. A narrative review of care for patients on maintenance kidney replacement therapy during the COVID-19 era. Pediatric Medicine. 2021;4","DOI":"10.21037\/pm-20-101"},{"key":"9832_CR4","doi-asserted-by":"publisher","unstructured":"Sperl-Hillen JM, Crain AL, Chumba L, et al. Pragmatic clinic randomized trial to improve chronic Kidney disease care: Design and adaptation due to COVID disruptions. Contemp Clin Trials. Oct 2021;109ARTN 106501, https:\/\/doi.org\/10.1016\/j.cct.2021.106501","DOI":"10.1016\/j.cct.2021.106501"},{"issue":"36","key":"9832_CR5","doi-asserted-by":"publisher","first-page":"1250","DOI":"10.15585\/mmwr.mm6936a4","volume":"69","author":"ME Czeisler","year":"2020","unstructured":"Czeisler ME, Marynak K, Clarke KEN, et al. Delay or Avoidance of Medical Care Because of COVID-19-Related Concerns - United States, June 2020. MMWR Morb Mortal Wkly Rep. Sep 11 2020;69(36):1250-1257. https:\/\/doi.org\/10.15585\/mmwr.mm6936a4","journal-title":"MMWR Morb Mortal Wkly Rep."},{"issue":"10","key":"9832_CR6","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1038\/s41581-020-00340-z","volume":"16","author":"S Alasfar","year":"2020","unstructured":"Alasfar S, Avery RK. The impact of COVID-19 on kidney transplantation. Nat Rev Nephrol. Oct 2020;16(10):568-569. https:\/\/doi.org\/10.1038\/s41581-020-00340-z","journal-title":"Nat Rev Nephrol."},{"issue":"11\u201312","key":"9832_CR7","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1159\/000532105","volume":"54","author":"S Patel","year":"2023","unstructured":"Patel S, Rivera EAT, Raman VK, et al. Impact of the COVID-19 pandemic on the provision of dialysis service and mortality in Veterans receiving maintenance hemodialysis in the VA: an interrupted time-series analysis. Am J Nephrol. Dec 2023;54(11-12):508-515. https:\/\/doi.org\/10.1159\/000532105","journal-title":"Am J Nephrol."},{"issue":"8","key":"9832_CR8","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1007\/s11255-020-02740-3","volume":"53","author":"R Cai","year":"2021","unstructured":"Cai R, Zhang J, Zhu Y, Liu L, Liu Y, He Q. Mortality in chronic kidney disease patients with COVID-19: a systematic review and meta-analysis. Int Urol Nephrol. Aug 2021;53(8):1623-1629. https:\/\/doi.org\/10.1007\/s11255-020-02740-3","journal-title":"Int Urol Nephrol."},{"key":"9832_CR9","doi-asserted-by":"publisher","unstructured":"Banco D, Kanchi R, Divers J, et al. Effect of COVID-19 Pandemic Related Healthcare Disruption on Hypertension Control: A Retrospective Analysis of Older Adults with Multiple Chronic Conditions in New York City. Am J Hypertens. Feb 7 2025;https:\/\/doi.org\/10.1093\/ajh\/hpaf013","DOI":"10.1093\/ajh\/hpaf013"},{"issue":"4","key":"9832_CR10","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1136\/amiajnl-2014-002764","volume":"21","author":"R Kaushal","year":"2014","unstructured":"Kaushal R, Hripcsak G, Ascheim DD, et al. Changing the research landscape: the New York City Clinical Data Research Network. J Am Med Inform Assoc. Jul-Aug 2014;21(4):587-90. https:\/\/doi.org\/10.1136\/amiajnl-2014-002764","journal-title":"J Am Med Inform Assoc. Jul-Aug"},{"key":"9832_CR11","doi-asserted-by":"publisher","first-page":"E61","DOI":"10.5888\/pcd10.120137","volume":"10","author":"KA Lochner","year":"2013","unstructured":"Lochner KA, Cox CS. Prevalence of multiple chronic conditions among Medicare beneficiaries, United States, 2010. Prev Chronic Dis. Apr 25 2013;10:E61. https:\/\/doi.org\/10.5888\/pcd10.120137","journal-title":"Prev Chronic Dis."},{"issue":"4","key":"9832_CR12","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1177\/003335491112600403","volume":"126","author":"AK Parekh","year":"2011","unstructured":"Parekh AK, Goodman RA, Gordon C, Koh HK. Managing multiple chronic conditions: a strategic framework for improving health outcomes and quality of life. Public Health Rep. Jul-Aug 2011;126(4):460-71. https:\/\/doi.org\/10.1177\/003335491112600403","journal-title":"Public Health Rep. Jul-Aug"},{"issue":"6","key":"9832_CR13","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.1111\/j.1523-1755.2005.00365.x","volume":"67","author":"AS Levey","year":"2005","unstructured":"Levey AS, Eckardt KU, Tsukamoto Y, et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. Jun 2005;67(6):2089-100. https:\/\/doi.org\/10.1111\/j.1523-1755.2005.00365.x","journal-title":"Kidney Int."},{"issue":"4","key":"9832_CR14","doi-asserted-by":"publisher","first-page":"543","DOI":"10.2215\/CJN.15691020","volume":"16","author":"SV Vestergaard","year":"2021","unstructured":"Vestergaard SV, Christiansen CF, Thomsen RW, Birn H, Heide-Jorgensen U. Identification of Patients with CKD in Medical Databases: A Comparison of Different Algorithms. Clin J Am Soc Nephrol. Apr 7 2021;16(4):543-551. https:\/\/doi.org\/10.2215\/CJN.15691020","journal-title":"Clin J Am Soc Nephrol."},{"issue":"19","key":"9832_CR15","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","volume":"385","author":"LA Inker","year":"2021","unstructured":"Inker LA, Eneanya ND, Coresh J, et al. New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race. N Engl J Med. Nov 4 2021;385(19):1737-1749. https:\/\/doi.org\/10.1056\/NEJMoa2102953","journal-title":"N Engl J Med."},{"key":"9832_CR16","doi-asserted-by":"publisher","unstructured":"Kidney Disease: Improving Global Outcomes CKDWG. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int. Apr 2024;105(4S):S117-S314. https:\/\/doi.org\/10.1016\/j.kint.2023.10.018","DOI":"10.1016\/j.kint.2023.10.018"},{"issue":"1","key":"9832_CR17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.kint.2019.01.017","volume":"96","author":"CT Chan","year":"2019","unstructured":"Chan CT, Blankestijn PJ, Dember LM, et al. Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. Jul 2019;96(1):37-47. https:\/\/doi.org\/10.1016\/j.kint.2019.01.017","journal-title":"Kidney Int."},{"issue":"1","key":"9832_CR18","doi-asserted-by":"publisher","first-page":"e2350009","DOI":"10.1001\/jamanetworkopen.2023.50009","volume":"7","author":"V Hemmige","year":"2024","unstructured":"Hemmige V, Deshpande P, Norris KC, et al. Geographic Dialysis Facility Density and Early Dialysis Initiation. JAMA Network Open. 2024;7(1):e2350009-e2350009. https:\/\/doi.org\/10.1001\/jamanetworkopen.2023.50009","journal-title":"JAMA Network Open."},{"issue":"1","key":"9832_CR19","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1053\/j.semvascsurg.2021.02.010","volume":"34","author":"R Gupta","year":"2021","unstructured":"Gupta R, Woo K, Yi JA. Epidemiology of end-stage kidney disease. Semin Vasc Surg. Mar 2021;34(1):71-78. https:\/\/doi.org\/10.1053\/j.semvascsurg.2021.02.010","journal-title":"Semin Vasc Surg."},{"issue":"8","key":"9832_CR20","doi-asserted-by":"publisher","first-page":"1237","DOI":"10.1093\/ndt\/gfu320","volume":"30","author":"K Leffondre","year":"2015","unstructured":"Leffondre K, Boucquemont J, Tripepi G, Stel VS, Heinze G, Dunkler D. Analysis of risk factors associated with renal function trajectory over time: a comparison of different statistical approaches. Nephrol Dial Transplant. Aug 2015;30(8):1237-43. https:\/\/doi.org\/10.1093\/ndt\/gfu320","journal-title":"Nephrol Dial Transplant."},{"key":"9832_CR21","doi-asserted-by":"publisher","unstructured":"Karattuthodi MS, Thorakkattil SA, Abdulsalim S, et al. The Pharmacist's Role in Managing COVID-19 in Chronic Kidney Disease Patients: A Review of Existing Strategies and Future Implications. Pharmacy (Basel). Aug 5 2022;10(4)https:\/\/doi.org\/10.3390\/pharmacy10040094","DOI":"10.3390\/pharmacy10040094"},{"issue":"1","key":"9832_CR22","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.sapharm.2020.07.008","volume":"17","author":"RN Okoro","year":"2021","unstructured":"Okoro RN. COVID-19 pandemic: The role of community pharmacists in chronic kidney disease management supportive care. Res Social Adm Pharm. Jan 2021;17(1):1925-1928. https:\/\/doi.org\/10.1016\/j.sapharm.2020.07.008","journal-title":"Res Social Adm Pharm."},{"issue":"1","key":"9832_CR23","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13561-024-00553-z","volume":"14","author":"WL Huang","year":"2024","unstructured":"Huang WL, Liao SL, Huang HL, et al. Impact of post-COVID-19 changes in outpatient chronic patients' healthcare-seeking behaviors on medical utilization and health outcomes. Health Econ Rev. Sep 5 2024;14(1):71. https:\/\/doi.org\/10.1186\/s13561-024-00553-z","journal-title":"Health Econ Rev."},{"issue":"11","key":"9832_CR24","doi-asserted-by":"publisher","first-page":"815","DOI":"10.2217\/cer-2022-0059","volume":"11","author":"K Engelbrecht","year":"2022","unstructured":"Engelbrecht K, Roy S, Capkun G, Kahler K, Olson M. Impact of the COVID-19 pandemic on healthcare resource utilization across selected disease areas in the USA. J Comp Eff Res. Aug 2022;11(11):815-828. https:\/\/doi.org\/10.2217\/cer-2022-0059","journal-title":"J Comp Eff Res."},{"key":"9832_CR25","doi-asserted-by":"publisher","unstructured":"Sim B, Nam EW. The Impact of COVID-19 Pandemic on Outpatient Visits for All-Cause and Chronic Diseases in Korea: A Nationwide Population-Based Study. Int J Environ Res Public Health. May 6 2022;19(9)https:\/\/doi.org\/10.3390\/ijerph19095674","DOI":"10.3390\/ijerph19095674"},{"issue":"1","key":"9832_CR26","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000512211","volume":"46","author":"B Wang","year":"2021","unstructured":"Wang B, Luo Q, Zhang W, et al. The Involvement of Chronic Kidney Disease and Acute Kidney Injury in Disease Severity and Mortality in Patients with COVID-19: A Meta-Analysis. Kidney Blood Press Res. 2021;46(1):17-30. https:\/\/doi.org\/10.1159\/000512211","journal-title":"Kidney Blood Press Res."},{"issue":"7","key":"9832_CR27","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","volume":"3","author":"K Matsushita","year":"2015","unstructured":"Matsushita K, Coresh J, Sang Y, et al. Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data. Lancet Diabetes Endocrinol. Jul 2015;3(7):514-25. https:\/\/doi.org\/10.1016\/S2213-8587(15)00040-6","journal-title":"Lancet Diabetes Endocrinol."},{"key":"9832_CR28","first-page":"419","volume":"120","author":"RJ Glassock","year":"2009","unstructured":"Glassock RJ, Winearls C. Ageing and the glomerular filtration rate: truths and consequences. Trans Am Clin Climatol Assoc. 2009;120:419-28.","journal-title":"Trans Am Clin Climatol Assoc."},{"issue":"15","key":"9832_CR29","doi-asserted-by":"publisher","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","volume":"383","author":"HJL Heerspink","year":"2020","unstructured":"Heerspink HJL, Stefansson BV, Correa-Rotter R, et al. Dapagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. Oct 8 2020;383(15):1436-1446. https:\/\/doi.org\/10.1056\/NEJMoa2024816","journal-title":"N Engl J Med."},{"key":"9832_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanwpc.2023.100988","volume":"43","author":"BL Neuen","year":"2024","unstructured":"Neuen BL, Jun M, Wick J, et al. Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data. Lancet Reg Health West Pac. Feb 2024;43:100988. https:\/\/doi.org\/10.1016\/j.lanwpc.2023.100988","journal-title":"Lancet Reg Health West Pac."},{"issue":"2","key":"9832_CR31","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1056\/NEJMoa2403347","volume":"391","author":"V Perkovic","year":"2024","unstructured":"Perkovic V, Tuttle KR, Rossing P, et al. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. N Engl J Med. Jul 11 2024;391(2):109-121. https:\/\/doi.org\/10.1056\/NEJMoa2403347","journal-title":"N Engl J Med."},{"issue":"23","key":"9832_CR32","doi-asserted-by":"publisher","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","volume":"383","author":"GL Bakris","year":"2020","unstructured":"Bakris GL, Agarwal R, Anker SD, et al. Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med. Dec 3 2020;383(23):2219-2229. https:\/\/doi.org\/10.1056\/NEJMoa2025845","journal-title":"N Engl J Med."},{"issue":"6","key":"9832_CR33","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1097\/MCC.0000000000000988","volume":"28","author":"K Matsumoto","year":"2022","unstructured":"Matsumoto K, Prowle JR. COVID-19-associated AKI. Curr Opin Crit Care. Dec 1 2022;28(6):630-637. https:\/\/doi.org\/10.1097\/MCC.0000000000000988","journal-title":"Curr Opin Crit Care."},{"issue":"12","key":"9832_CR34","doi-asserted-by":"publisher","first-page":"e2450014","DOI":"10.1001\/jamanetworkopen.2024.50014","volume":"7","author":"V Mahalingasivam","year":"2024","unstructured":"Mahalingasivam V, Faucon AL, Sjolander A, et al. Kidney Function Decline After COVID-19 Infection. JAMA Netw Open. Dec 2 2024;7(12):e2450014. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.50014","journal-title":"JAMA Netw Open."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09832-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-09832-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-09832-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:02:24Z","timestamp":1788480144000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-025-09832-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,4]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["9832"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-09832-9","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,4]]},"assertion":[{"value":"15 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"RL, RA, SEC, RK, JAD, LET, MAMD, and WW have no conflicts to report. SBB has an ownership stake in Vineland Dialysis. DMC reports consulting fees from Eli Lilly\/Boehringer Ingelheim, Astra ZenecaAllena, Pharmaceuticals (DSMB), Gilead, Novo Nordisk, GSK, Medtronic, Merck, CSL Behring, Zogenix, Renalytix, LG Chemical, Alentis Therapeutics; Research funding from Medtronic; Clinical trial support from Gilead, NovoNordisk, Amgen, Boehringer Ingelheim\/Eli Lilly; Patents or royalties: UpToDate.com; and fees related to editorial work at CJASN.","order":1,"name":"Ethics","label":"Conflicts of Interest:","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Human Ethics and Consent to Participate:","group":{"name":"EthicsHeading","label":"Declarations:"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}